000908 *ST景峰医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-7.344-373.215-54.114-43.523-98.320
总资产报酬率 ROA (%)0.325-17.089-7.585-6.887-27.773
投入资产回报率 ROIC (%)0.535-27.391-11.048-9.446-36.179

边际利润分析
销售毛利率 (%)66.35171.75876.28862.08763.785
营业利润率 (%)5.104-26.322-8.127-15.401-115.668
息税前利润/营业总收入 (%)14.427-20.233-4.084-7.205-106.815
净利润/营业总收入 (%)4.971-31.436-11.331-23.506-119.279

收益指标分析
经营活动净收益/利润总额(%)-61.17378.41958.938249.94662.127
价值变动净收益/利润总额(%)-0.548-16.647-16.140-177.348-21.375
营业外收支净额/利润总额(%)-1.5830.43520.22013.5302.713

偿债能力分析
流动比率 (X)0.2400.2050.5270.4980.550
速动比率 (X)0.1810.1430.4160.3840.425
资产负债率 (%)113.514114.49386.16682.55777.107
带息债务/全部投入资本 (%)91.97092.29570.98770.08768.523
股东权益/带息债务 (%)-7.660-8.14825.43231.48431.313
股东权益/负债合计 (%)-3.682-4.07713.12119.67820.160
利息保障倍数 (X)1.534-3.261-0.669-0.679-8.844

营运能力分析
应收账款周转天数 (天)75.85567.16879.197143.424233.146
存货周转天数 (天)170.465179.444249.019226.966316.292